Publications by authors named "Sharon Giveon"
Background: Teriparatide (TPTD) should be followed by an antiresorptive to maximize bone mineral density gain and anti-fracture protection. Infrequent zoledronic acid (ZOL) administration has demonstrated effectiveness. The duration of ZOL effect following TPTD is unknown.
View Article and Find Full Text PDFArticle Synopsis
- - The study aimed to assess the occurrence of positive whole-body scans (WBS) in patients with negative stimulated thyroglobulin (sTg) levels and their clinical characteristics, as well as their disease outcomes.
- - Out of 272 differentiated thyroid cancer patients followed for an average of 11.6 years, 17.3% had positive WBS despite having negative sTg, with no significant differences in mortality across different test results.
- - The findings suggest that routine WBS can provide meaningful information for a small number of patients who otherwise show no signs of disease, highlighting its potential role in treatment decisions.